Rasoul Aliannejad

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost et al. · JAMA · 2021 · 653 citations · Full text

Pharmacy, Pharmacotherapy, Critical Care Pharmacology +16

Whole-genome sequencing reveals host factors underlying critical COVID-19

Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik et al. · Nature · 2022 · 347 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

Seyed Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi et al. · Stem Cell Research & Therapy · 2021 · 208 citations · Full text

Medicine, Internal Medicine, Cell Therapy +16

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

Anahita Sadeghı, Ali Asgari, Alireza Norouzi et al. · Journal of Antimicrobial Chemotherapy · 2020 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial

Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri et al. · Stem Cell Research & Therapy · 2023 · 91 citations · Full text

Medicine, Cell Biology, Infectious Diseases +17